Antifungal Drugs

Introduction to Fungal Infections and Antifungal Therapy

Fungal infections, known as mycoses, range from mild superficial skin conditions to severe, life-threatening systemic illnesses. Treating these infections presents a unique clinical challenge because fungi are eukaryotes. Unlike bacteria, fungal cells share similar biochemical and structural features with human host cells. Consequently, finding selective targets that harm the pathogen without damaging the patient's cells is difficult.

Fungi rely on specific components for survival and growth. The fungal cell wall contains chitin and beta-glucan, while the cell membrane contains ergosterol instead of the cholesterol found in human membranes. Most antifungal agents exploit these biochemical differences to exert their therapeutic effects. Understanding these structural targets forms the foundation of safe and effective pharmacology in nursing practice.

Classification and Mechanisms of Action

Antifungal drugs are classified based on their chemical structure, spectrum of activity, and mechanism of action. Broadly, they either inhibit fungal growth (fungistatic) or actively kill the fungi (fungicidal).

• Cell membrane disruptors: Bind directly to fungal sterols to create pores, causing intracellular leakage.
• Synthesis inhibitors: Block the enzymatic pathways responsible for building ergosterol or cell wall components.
• Nucleic acid synthesis inhibitors: Interfere with fungal RNA and DNA replication processes.

Systemic Antifungal Drugs: Polyenes and Azoles

Systemic fungal infections require potent medications that can reach deep tissues and internal organs.

• Polyenes: Amphotericin B is the gold standard for severe systemic mycoses. It binds to ergosterol, forming pores in the membrane. It is famously toxic, often referred to as 'amphotericin terrible' due to infusion reactions and nephrotoxicity.
• Azoles: Divided into imidazoles (like ketoconazole) and triazoles (like fluconazole and itraconazole). They inhibit the enzyme lanosterol 14-alpha-demethylase, halting ergosterol synthesis. Fluconazole is widely used in tropical settings for cryptococcal meningitis in immunocompromised patients.

Superficial Antifungal Drugs: Echinocandins and Allylamines

For infections limited to the skin, hair, nails, and mucous membranes, different drug classes are preferred.

• Echinocandins: Such as caspofungin, these inhibit the synthesis of beta-D-glucan, an essential component of the fungal cell wall. They are administered intravenously for invasive candidiasis and aspergillosis.
• Allylamines: Terbinafine inhibits squalene epoxidase, an early enzyme in ergosterol biosynthesis. This leads to an accumulation of toxic squalene within the fungal cell. Terbinafine is highly effective for dermatophyte infections of the nails (onychomycosis) due to its affinity for keratinized tissues.

Clinical Uses in Nigerian Healthcare Settings

In tropical environments like Nigeria, fungal infections present unique epidemiological patterns. Superficial mycoses such as tinea capitis (ringworm of the scalp) are common among school-aged children, often treated with oral griseofulvin or topical azoles.

Systemic and opportunistic fungal infections are frequently encountered in clinical wards managing immune-compromised individuals, particularly patients living with advanced HIV/AIDS. Oral candidiasis (oral thrush) and cryptococcal meningitis require prompt identification and guideline-based therapy using affordable, accessible agents like nystatin suspension and fluconazole.

Adverse Effects and Drug Interactions

Antifungal medications carry significant risk profiles that demand careful clinical monitoring.

• Amphotericin B Toxicity: Causes severe rigors, fever, hypokalemia, and nephrotoxicity. Pre-medication with antipyretics and normal saline loading helps mitigate these effects.
• Hepatotoxicity: Many azoles can elevate liver enzymes, requiring baseline and periodic liver function tests.
• Cytochrome P450 Interactions: Azoles are potent inhibitors of the hepatic CYP450 enzyme system. This leads to dangerous accumulation of co-administered drugs such as warfarin, phenytoin, and certain antiretrovirals.

Nursing Responsibilities and Patient Education

Nurses play a vital role in ensuring safe medication administration and adherence during antifungal therapy. Before starting systemic treatment, baseline renal function, liver enzymes, and electrolyte levels must be documented. During intravenous infusions of medications like amphotericin B, nurses monitor vital signs closely for acute infusion-related reactions.

Patient education focuses on completing the full course of treatment, even if symptoms subside early. For topical creams and suspensions, proper application techniques are demonstrated to ensure contact with the affected area. Nurses also advise patients on recognizing early signs of toxicity, such as dark urine, yellowing of the eyes, or persistent nausea.